Trial intelligence / Profile preview

Difluprednate vs Prednisolone for Post-Cataract Inflammation in Children

NCT01124045Phase 3Completed

Sponsor
Alcon Inc.
Start
Aug 2010
Primary completion
Apr 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of difluprednate in inflammation, sponsored by Alcon Inc.. Started Aug 2010; status: completed.

02

Drugs

difluprednate
03

Conditions

inflammation

Beyond the preview

Go deeper on NCT01124045.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01124045.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call